Aktuellt
SENASTE
Redeye comments on Gasporox’s Q2’23 report, which was significantly stronger than expected on all items. Sensors were the main driver of sales, while instruments also contributed positively. We are still cautious about extrapolating the results and will likely keep our current estimates and fair value range. However, we expect the share to close to our base case.
LÄS MER
